Canon Medical Systems Corporation and Resoundant, Inc. (Rochester, MN, USA) have signed a licensing agreement for the purpose of incorporating the advanced Magnetic Resonance Elastography (MRE), developed by Resoundant on the Canon MRI platforms.
“We are excited to continue expanding our applications of body MR imaging by adding this technology that Resoundant has worked so well at establishing and improving. Resoundant is the pioneer in MRE and we are enthusiastic about the possibilities this relationship will bring to our customers.” said Akira Adachi, General Manager, MRI Systems Division at Canon Medical
“We’re thrilled to see MRE become available on Canon’s world-class MRI systems,” said Richard Ehman, MD, professor of Radiology and the Blanche R. & Richard J. Erlanger Professor of Medical Research at Mayo Clinic and CEO of Resoundant “One of our highest priorities is ensuring access to MRE anywhere in the world. Partnering with Canon helps us do that, as their footprint continues to expand rapidly.”
About MRE
MR Elastography was invented at Mayo Clinic and is the only MRI technology that has been validated for staging liver fibrosis. It is currently available to clinicians at over 1,800 locations across the globe. The role of MRE has been increasingly recognized in multidisciplinary clinical guidelines for noninvasive liver fibrosis assessment, particularly in suspected cases of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). The American College of Radiology issued Appropriateness Criteria® that identify MRE as the most accurate and applicable noninvasive liver fibrosis exam. In the US, MRE is reimbursed via a Category I CPT® code (76391) and is covered by numerous public and private insurance plans.
About Resoundant
Resoundant, Inc. is a medical technology company dedicated to improving patient care and diagnosis accuracy by making Magnetic Resonance Elastography (MRE) available around the world. Resoundant is based in Rochester, MN and was founded by Mayo Foundation for Medical Education & Research, Mayo Clinic physicians and researchers.
For more information, go to http://www.resoundant.com
About Canon Medical Systems
Canon Medical Systems has the largest share of the diagnostic imaging equipment market in Japan* and has long been a world leader in the development of advanced imaging technologies, such as the AI-based Advanced intelligent Clear-IQ Engine (AiCE) deep learning reconstruction platform for removing noise from images.
Canon Medical offers a full range of diagnostic medical imaging solutions including CT, X-Ray, Ultrasound, Vascular and MR, as well as a full suite of Healthcare IT solutions, across the globe. In line with our continued Made for Life philosophy, patients are at the heart of everything we do. Our mission is to provide medical professionals with solutions that support their efforts in contributing to the health and wellbeing of patients worldwide. Our goal is to deliver optimum health opportunities for patients through uncompromised performance, comfort and safety features.
At Canon Medical, we work hand in hand with our partners – our medical, academic and research community. We build relationships based on transparency, trust and respect. Together as one, we strive to create industry-leading solutions that deliver an enriched quality of life.
For more information, visit the Canon Medical website: https://global.medical.canon.
* Based on internal company data for five imaging modalities (CT, MRI, ultrasound, X-ray, and nuclear medicine).
View source version on businesswire.com: https://www.businesswire.com/news/home/20211130005874/en/
Contacts
for Resoundant
Michael Kalutkiewicz
Vice President of Policy and Communications
mkalutkiewicz@resoundant.com
for Canon Medical Systems
Hiroko Eno
General Manager, Public Relations Dept.
hiroko.eno@medical.canon
Source: Canon Medical Systems Corporation
View this news release online at:
http://www.businesswire.com/news/home/20211130005874/en
